Oxalate toxicity in renal cells

Urological Research

Volumn 33, Issue 5, 2005, Pages 329-339

  Jonassen, Julie A ^a   Kohjimoto, Yasuo ^b   Scheid, Cheryl R ^a   Schmidt, Madelyn ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cyclooxygenase; Kidney; Lysophosphatidylcholine; Oxalate; Phospholipase A2; Toll like receptors

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 2; ENDOTOXIN; I KAPPA B; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; OXALIC ACID; PROSTANOID; TOLL LIKE RECEPTOR 4;

ADAPTATION; ANIMAL CELL; BACTERIAL CELL WALL; CATALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; DESENSITIZATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; INFLAMMATION; KIDNEY CELL; KIDNEY EPITHELIUM; KIDNEY FUNCTION; LIPOGENESIS; NEPHROLITHIASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RENAL PROTECTION; UPREGULATION;

ANIMALS; CELLS, CULTURED; CYCLOOXYGENASE 2; DOGS; EPITHELIAL CELLS; HUMANS; KIDNEY CALCULI; KIDNEY TUBULES, PROXIMAL; LIPOPOLYSACCHARIDES; OXALATES; PHOSPHOLIPASES A; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; UP-REGULATION;

EID: 28644435463     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00240-005-0485-3     Document Type: Conference Paper

References (76)

1. Tiselius HG (2003) Epidemiology and medical management of stone disease. BJU Int 91:758-767
2. Robertson WG (2004) Kidney models of calcium oxalate stone formation. Nephron Physiol 98:21-30
3. Marangella M, Bagnis C, Bruno M, Vitale C, Petrarulo M, Ramello A (2004) Crystallization inhibitors in the pathophysiology and treatment of nephrolithiasis. Urol Int 72 [Suppl 1]:6-10
4. Khan SR (2004) Role of renal epithelial cells in the initiation of calcium oxalate stones. Nephron Exp Nephrol 98:55-60
5. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 63:1817-1823
6. Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M (2003) Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111:607-616
7. Khan SR, Shevock PN,Hackett RL (1992) Acute hyperoxaluria renal injury and calcium oxalate urolithiasis. J Urol 147:226-230
8. Asselman M, Verhulst A, DrBroe ME, Verkoelen CF (2003) Calcium oxalate crystal adherence to hyaluronan-osteopontin-and CD44-expressing injured/regenerating tubular epithelial cells in rat kidneys. J Am Soc Nephrol 14:3155-3166
9. Verkoelen CF, Van der Boom BG, Houtsmuller AB, Schroder FH, Romijn JC (1998) Increased calcium oxalate monohydrate crystal binding to injured renal tubular epithelial cells in culture. Am J Physiol 274:F958-965
10. Farell G, Huang E, Kim SY, Horstkorte R, Lieske JC (2004) Modulation of proliferating renal epithelial cell affinity for calcium oxalate monohydrate crystals. J Am Soc Nephrol 15:3052-3062
11. Wiessner JH, Hasegawa AT, Hung LY, Mandel GS, Mandel NS (2001) Mechanisms of calcium oxalate crystal attachment to injured renal collecting duct cells. Kidney Int 59:637-644
12. Khan SR, Byer KJ, Thamilselvan S, Hackett RL, McCormack WT, Benson NA, Vaughn KL, Erdos GW (1999) Crystal-cell interaction and apoptosis in oxalate-associated injury of renal epithelial cells. Am Soc Nephrol 10 [Suppl 14]: S457-S463
13. Khan SR, Hackett RL (1993) Role of organic matrix in urinary stone formation: an ultrastructural study of crystal matrix interface of calcium oxalate monohydrate stones. J Urol 150:239-245
14. Jonassen JA, Cao LC, Honeyman TW, Scheid CR (2003) Mechanisms mediating oxalate-induced alterations in renal cell functions. Crit Rev Eukaryot Gene Expr 13:55-72
15. Scheid CR, Cao L-C, Honeyman T, Jonassen JA (2004) How elevated oxalate can promote kidney stone disease: changes at the surface and in the cytosol of renal cells that promote crystal adherence and growth. Front Biosci 9:797-808
16. Khan SR (2004) Crystal-induced inflammation of the kidneys: results from human studies animal models and tissue-culture studies. Clin Exp Nephrol 8:75-88
17. Asplin JR (2002) Hyperoxaluric calcium nephrolithiasis. Endocrinol Metab Clin North Am 31:927-949
18. Boer P, Van Leersum L, Hene RJ, Mees EJ (1984) Plasma oxalate concentration in chronic renal disease. Am J Kidney Dis 4:118-122
19. Holmes RP, Assimos DG (2004) The impact of dietary oxalate on kidney stone formation. Urol Res 32:311-316
20. Baggio B, Gambaro G, Ossi E, Favaro, S Borsatti A (1983) Increased urinary excretion of renal enzymes in idiopathic calcium oxalate nephrolithiasis. J Urol 129:1161-1162
21. Cao LC, Jonassen J, Honeyman TW, Scheid C (2001) Oxalate-induced redistribution of phosphatidylserine in renal epithelial cells: implications for kidney stone disease. Am J Nephrol 21:69-77
22. Khan SR, Cockrell CA, Finlayson B, Hackett RL (1984) Crystal retention by injured urothelium of the rat urinary bladder. J Urol 132:153-157
23. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148:2207-2216
24. Cao LC, Honeyman T, Jonassen J, Scheid C (2000) Oxalate-induced ceramide accumulation in Madin-Darby canine kidney and LLC-PK1 cells. Kidney Int 57:2403-2411
25. Kohjimoto Y, Kennington L, Scheid CR, Honeyman TW (1999) Role of phospholipase A2 in the cytotoxic effects of oxalate in cultured renal epithelial cells. Kidney Int 56:1432-1441
26. Kohjimoto Y, Honeyman TW, Jonassen J, Gravel K, Kennington L, Scheid CR (2000) Phospholipase A2 mediates immediate early genes in cultured renal epithelial cells: possible role of lysophospholipid. Kidney Int 58:638-646
27. Cao LC, Honeyman TW, Cooney R, Kennington L, Scheid CR, Jonassen JA (2004) Mitochondrial dysfunction is a primary event in renal cell oxalate toxicity. Kidney Int 66:1890-1900
28. Thamilselvan S, Khan SR, Menon M (2003) Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res 31:3-9
29. Khand FD, Gordge MP, Robertson WG, Noronha-Dutra AA, Hothersall JS (2002) Mitochondrial superoxide production during oxalate-mediated oxidative stress in renal epithelial cells. Free Radic Biol Med 32:1339-1350
30. Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssiere JL, Petit PX, Kroemer G (1995) Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 182:367-377
31. McMartin KE, Wallace KB (2004) Calcium oxalate monohydrate, a metabolite of ethylene glycol, is toxic for rat renal mitochondrial function. Toxicol Sci 84:195-200
32. Nath KA, Norby SM (2000) Reactive oxygen species and acute renal failure. Am J Med 109:665-678
33. Selvam R (2002) Calcium oxalate stone disease: role of lipid peroxidation and antioxidants. Urol Res 30:35-47
34. Huang HS, Ma MC, Chen CF, Chen J (2003) Lipid peroxidation and its correlations with urinary levels of oxalate citric acid and osteopontin in patients with renal calcium oxalate stones. Urology 62:1123-1128
35. Tungsanga K, Sriboonlue P, Futrakul P, Yachantha C, Tosukhowong P (2005) Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment. Urol Res 33:35-69
36. Kleinman JG, Wesson JA, Hughes J (2004) Osteopontin and calcium stone formation. Nephron Physiol 98:43-47
37. Worcester EM, Kleinman JG, Beshensky AM (1995) Osteopontin production by cultured kidney cells. Ann N Y Acad Sci 760:266-278
38. Umekawa T, Yamate T, Amasaki N, Kohri K, Kurita T (1995) Osteopontin mRNA in the kidney on an experimental rat model of renal stone formation without renal failure. Urol Int 5:6-10
39. Mazzali M, Kipari T, Ophascharoensuk V, Wesson JA, Johnson R, Hughes J (2002) Osteopontin - a molecule for all seasons. Q J Med 95:3-13
40. e Water R, Noordermeer C, Van der Kwast TH, Nizze H, Boeve ER, Kok DJ, Schroder FH (1999) Calcium oxalate nephrolithiasis: effect of renal crystal deposition on the cellular composition of the renal interstitium. Am J Kidney Dis 33:761-771
41. De Water R, Noordermeer C, Houtsmuller AB, Nigg AL, Stijnen T, Schroder FH, Kok DJ (2000) Role of macrophages in nephrolithiasis in rats: an analysis of the renal interstitium. Am J Kidney Dis 36:615-625
42. Katsuma S, Shiojima S, Hirasawa A, Takagaki K, Kaminishi Y, Koba M, Hagidai Y, Murai M, Ohgi T, Yano J, Tsujimoto G (2002) Global analysis of differentially expressed genes during progression of calcium oxalate nephrolithiasis. Biochem Biophys Res Commun 296:544-552
43. Chen DH, Kaung HL, Miller CM, Resnick MI, Marengo SR (2004) Microarray analysis of changes in renal phenotype in the ethylene glycol rat model of urolithiasis: potential and pitfalls. BJU Int 94:637-650
44. Denhardt DT, Giachelli CM, Rittling SR (2001) Role of osteopontin in cellular signaling and toxicant injury. Annu Rev Pharmacol Toxicol 41:723-774
45. Verkoelen CF, Schepers MS (2000) Changing concepts in the aetiology of renal stones. Curr Opin Urol 10:539-544
46. Cao Z, Cooper ME (2001) Role of angiotensin II in tubulointerstitial injury. Semin Nephrol 21:554-562
47. Antus B, Exton MS, Rosivall L (2001) Angiotensin II: a regulator of inflammation during renal disease? Int J Immunopathol Pharmacol 14:25-30
48. Toblli, JE Stella I, De Cavanagh E, Angerosa M, Inserra F, Ferder L (1999) Enalapril prevents tubulointerstitial lesions by hyperoxaluria. Hypertension 33:225-231
49. Toblli JE, Ferder L, Stella I, Angerosa M, Inserra F (2001) Protective role of enalapril for chronic tubulointerstitial lesions of hyperoxaluria. J Urol 166:275-280
50. Toblli JE, Ferder L, Stella I, De Cavanaugh EM, Angerosa M, Inserra F (2002) Effects of angiotensin II subtype 1 receptor blockade by losartan on tubulointerstitial lesions caused by hyperoxaluria. J Urol 168:1550-1555
51. Umekawa T, Hatanaka Y, Kurita T, Khan SR (2004) Effect of angiotensin II receptor blockage on osteopontin expression and calcium oxalate crystal deposition in rat kidneys. J Am Soc Nephrol 15:635-644
52. Turan T, Van Harten JG, De Water R, Tuncay OL, Kok DJ (2003) Is enalapril adequate for the prevention of renal tissue damage caused by unilateral ureteral obstruction and/or hyperoxaluria? Urol Res 31:212-217
53. Umekawa T, Chegini N, Khan SR (2003) Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals. Nephrol Dial Transplant 18:664-669
54. Rhee E, Santiago L, Park E, Lad P, Bellman GC (1998) Urinary IL-6 is elevated in patients with urolithiasis. J Urol 160:2284-2288
55. Martinon F, Tschopp J (2004) Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117:561-574
56. Smith WL, DeWitt DL, Garavito RM (2000) Cyclooxygenases: structural cellular and molecular biology. Annu Rev Biochem 69:145-182
57. Harris RC, Breyer MD (2001) Physiological regulation of cyclooxygenase-2 in the kidney. Am J Physiol Renal Physiol 281:F1-F11
58. Cheng HF, Harris RC (2004) Cyclooxygenases, the kidney, and hypertension. Hypertension 43:525-530
59. Hata AN, Breyer RM (2004) Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol Ther 103:147-166
60. Scott KF, Bryant KJ, Bidgood MJ (1999) Functional coupling and differential regulation of the phospholipase A2-cyclooxygenase pathways in inflammation. J Leukoc Biol 66:535-541
61. Cook DN, Pisetsky DS, Schwartz DA (2004) Toll-like receptors in the pathogenesis of human disease. Nat Immunol 5:975-979
62. Akira S, Sato S (2003) Toll-like receptors and their signaling mechanisms. Scand J Infect Dis 35:555-562
63. Anders HJ, Banas B, Schlondorff D (2004) Signaling danger: toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol 15:854-867
64. Tobias P, Curtiss LK (2005) Thematic review series: the immune system and atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis. J Lipid Res 46:404-411
65. McAleer IM, Kaplan GW, Bradley JS, Carroll SF, Griffith DP (2003) Endotoxin content in renal calculi. J Urol 169:1813-1814
66. Rao PN, Dube DA, Weightman NC, Oppenheim BA, Morris J (1991) Prediction of septicemia following endourological manipulation for stones in the upper urinary tract. J Urol 146:955-960
67. Werness PG, Brown CM, Smith LH, Finlayson B (1985) EQUIL2: a BASIC computer program for the calculation of urinary saturation. J Urol 134:1242-1244
68. Ostrom RS, Gregorian C, Drenan RM, Gabot K, Rana BK, Insel PA (2001) Key role for constitutive cyclooxygenase-2 of MDCK cells in basal signaling and response to released ATP. Am J Physiol Cell Physiol 281:C524-C531
69. Schaefers HJ, Haselmann J, Goppelt-Struebe M (1996) Regulation of prostaglandin synthesis in Madin-Darby canine kidney cells: role of prostaglandin G/H synthase and secreted phospholipase A2. Biochim Biophys Acta 1300:197-202
70. Cowley BD, Muessel MJ, Douglass D, Wilkins W (1995) In vivo and in vitro osmotic regulation of HSP-70 and prostaglandin synthase gene expression in kidney cells. Am J Physiol 269:F854-F862
71. Jonassen JA, Kohjimoto Y, Scheid CR (2004) Oxalate exposure stimulates COX-2 in MDCK renal epithelial cells. In: Gohel MDI, D Au WT (eds) Kidney stones, inside & out. Hong Kong Polytechnic University Press, Hong Kong, pp 111-113
72. Lieske JC, Huang E, Toback FG (2000) Regulation of renal epithelial cell affinity for calcium oxalate monohydrate crystals. Am J Physiol Renal Physiol 278:F130-F137
73. Kelley VR, Singer GG (1993) The antigen presentation function of renal tubular epithelial cells. Exp Nephrol 1993 1:102-111
74. Wolfs TG, Buurman WA, Van Schadewijk A, De Vries B, Daemen MA, Hiemstra PS, Van 't Veer C (2002) In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation. J Immunol 168:1286-1293
75. Tsuboi N, Yoshikai Y, Matsuo S, Kikuchi T, Iwami K, Nagai Y, Takeuchi O, Akira S, Matsuguchi T (2002) Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol 169:2026-2033
76. Anders HJ, Vielhauer V, Schlondorff D (2003) Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int 63:401-415